ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Working Group to Look At Guidelines, Mandates, Centers Role In Prevention, Cancer Control

February 17, 1984

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

First NCAB “Road” Hearing In L.A.

September 18, 1987

NCI Plans $38 Million For New Research In Tobacco Control Over Next Two Years

October 16, 1998

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

October 30, 2009

Funding opportunities listed.

January 16, 2004